Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 2 |
Apple
AAPL
|
+$949M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$788M |
| 4 |
Microsoft
MSFT
|
+$654M |
| 5 |
Broadcom
AVGO
|
+$568M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.26B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$702M |
| 3 |
Tesla
TSLA
|
+$694M |
| 4 |
Micron Technology
MU
|
+$601M |
| 5 |
Strategy Inc
MSTR
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.3% |
| 2 | Technology | 1.97% |
| 3 | Financials | 0.89% |
| 4 | Consumer Discretionary | 0.83% |
| 5 | Healthcare | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMP
11326
PUT
Immutep
IMMP
$56.1M
| $102K | ﹤0.01% |
47,200
-20,600
| -30% | -$41.4K |
|
11327
Nauticus Robotics
KITT
$5.98M
| $102K | ﹤0.01% |
+915
| New | +$81.6K |
|
11328
CALL
Sight Sciences
SGHT
$463M
| $102K | ﹤0.01% |
28,000
-11,500
| -29% | -$52.4K |
|
11329
ADC Therapeutics
ADCT
$143M
| $102K | ﹤0.01% |
+51,198
| New | +$134K |
|
11330
PUT
Digital Turbine
APPS
$1.38B
| $102K | ﹤0.01% |
60,200
-17,500
| -23% | -$38.9K |
|
11331
PUT
Douglas Elliman
DOUG
$169M
| $102K | ﹤0.01% |
60,900
-454,900
| -88% | -$875K |
|
11332
PUT
AngioDynamics
ANGO
$652M
| $102K | ﹤0.01% |
+11,100
| New | +$81.6K |
|
11333
CALL
AbCellera Biologics
ABCL
$4.02B
| $102K | ﹤0.01% |
34,700
+22,900
| +194% | +$63.8K |
|
11334
CALL
Mistras Group
MG
$613M
| $101K | ﹤0.01% |
11,200
-4,300
| -28% | -$42.3K |
|
11335
Marchex
MCHX
$80.3M
| $101K | ﹤0.01% |
+57,970
| New | +$107K |
|
11336
Gain Therapeutics
GANX
$80.7M
| $101K | ﹤0.01% |
+46,913
| New | +$94.2K |
|
|
WOW
11337
PUT
DELISTED
WideOpenWest
WOW
| $101K | ﹤0.01% |
20,400
-5,200
| -20% | -$26.6K |
|
11338
CALL
Crexendo
CXDO
$213M
| $101K | ﹤0.01% |
19,300
-17,300
| -47% | -$91.5K |
|
11339
CALL
Sagimet Biosciences
SGMT
$668M
| $101K | ﹤0.01% |
+22,400
| New | +$113K |
|
|
KG
11340
Kestrel Group
KG
$59.3M
| $101K | ﹤0.01% |
2,979
+2,095
| +237% | +$67K |
|
11341
PUT
Resources Connection
RGP
$147M
| $101K | ﹤0.01% |
11,800
-2,700
| -19% | -$22.8K |
|
11342
CALL
Conduent
CNDT
$271M
| $101K | ﹤0.01% |
24,900
+3,900
| +19% | +$15.5K |
|
|
EMKR
11343
DELISTED
Emcore Corp
EMKR
| $101K | ﹤0.01% |
33,525
-3,943
| -11% | -$10.5K |
|
11344
PUT
MacroGenics
MGNX
$260M
| $100K | ﹤0.01% |
30,900
-10,100
| -25% | -$36.4K |
|
11345
Heartbeam
BEAT
$27.4M
| $100K | ﹤0.01% |
+43,600
| New | +$110K |
|
11346
Lesaka Technologies
LSAK
$391M
| $100K | ﹤0.01% |
+18,521
| New | +$96.5K |
|
11347
PUT
United States Antimony
UAMY
$772M
| $100K | ﹤0.01% |
+56,600
| New | +$56.8K |
|
|
ONTF
11348
DELISTED
ON24
ONTF
| $99.9K | ﹤0.01% |
+15,467
| New | +$99.3K |
|
11349
CALL
NovaGold Resources
NG
$4B
| $99.9K | ﹤0.01% |
30,000
-60,100
| -67% | -$212K |
|
11350
CALL
Cogent Biosciences
COGT
$6.44B
| $99.8K | ﹤0.01% |
12,800
-2,200
| -15% | -$21.9K |
|
Similar funds
Jeff Yass's Q4 2024 Portfolio in Review
As of Q4 2024, Jeff Yass held 13,659 positions worth $663B, up 16% from $572B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q4 2024 filing shows 1,862 new, 5,386 increased, 4,790 reduced and 1,590 closed positions. Its largest new stake was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $1.26B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 94% a quarter earlier, followed by Technology and Financials.
- Jeff Yass's largest Q4 2024 buy was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M.
- Jeff Yass added most to Invesco QQQ Trust in Q4 2024, an estimated $1.41B increase.
- Jeff Yass's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.26B.
- Jeff Yass fully exited NextEra Energy 7.299% Corporate Units in Q4 2024, selling an estimated $112M.
- Jeff Yass's ten largest holdings make up 28% of its $663B portfolio in Q4 2024.
- Jeff Yass opened 1,862 new positions and closed 1,590 in Q4 2024.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $663B.
Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.